Wellington Management Group LLP Eli Lilly & CO Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Wellington Management Group LLP holds 10,613,796 shares of LLY stock, worth $8.49 Billion. This represents 1.69% of its overall portfolio holdings.

Number of Shares

10,613,796

Previous 10,779,091 1.53%

Holding current value

$8.49 Billion

Previous $9.76 Billion 3.65%

% of portfolio

1.69%

Previous 1.78%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $128 Million - $159 Million	-165,295 Reduced 1.53%	10,613,796 $9.4 Billion
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $172 Million - $215 Million	-237,036 Reduced 2.15%	10,779,091 $9.76 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $6.52 Billion - $8.73 Billion	11,016,127 New	11,016,127 $8.57 Billion
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $6.19 Billion - $7.29 Billion	11,779,826 New	11,779,826 $6.87 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $694 Million - $957 Million	-1,596,844 Reduced 11.05%	12,854,465 $6.9 Billion
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $2.06 Billion - $2.75 Billion	-5,872,958 Reduced 28.9%	14,451,309 $6.78 Billion
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $97.6 Million - $115 Million	314,349 Added 1.57%	20,324,267 $6.98 Billion
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $590 Million - $687 Million	-1,833,370 Reduced 8.39%	20,009,918 $7.32 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $473 Million - $539 Million	-1,593,968 Reduced 6.8%	21,843,288 $7.06 Billion
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.06 Billion - $1.24 Billion	-3,786,064 Reduced 13.91%	23,437,256 $7.6 Billion
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $14.3 Million - $17.8 Million	-60,967 Reduced 0.22%	27,223,320 $7.8 Billion
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $247 Million - $306 Million	-1,097,779 Reduced 3.87%	27,284,287 $7.54 Billion
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $476 Million - $586 Million	-2,148,102 Reduced 7.04%	28,382,066 $6.56 Billion
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $227 Million - $294 Million	-1,258,811 Reduced 3.96%	30,530,168 $7.01 Billion
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $223 Million - $289 Million	-1,359,373 Reduced 4.1%	31,788,979 $5.94 Billion
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $1.02 Billion - $1.35 Billion	7,830,510 Added 30.93%	33,148,352 $5.6 Billion
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $245 Million - $283 Million	-1,672,936 Reduced 6.2%	25,317,842 $3.75 Billion
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $1.23 Billion - $1.48 Billion	-9,032,729 Reduced 25.07%	26,990,778 $4.43 Billion
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $991 Million - $1.23 Billion	-8,322,982 Reduced 18.77%	36,023,507 $5 Billion
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $4.74 Billion - $5.87 Billion	44,346,489 New	44,346,489 $5.83 Billion

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Eli Lilly & CO Transaction History